How should decision aids be developed, and which patient outcomes should be assessed?

Michael A. Diefenbach; Suzanne M. Miller

doi:10.1002/cncr.34247

How should decision aids be developed, and which patient outcomes should be assessed?

Michael A. Diefenbach
, Suzanne M. Miller

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2988-2989
Number of pages	2
Journal	Cancer
Volume	128
Issue number	15
DOIs	https://doi.org/10.1002/cncr.34247
State	Published - 1 Aug 2022
Externally published	Yes

Access to Document

10.1002/cncr.34247

Cite this

@article{f11967963be84d699c3e1a3eb945405d,

title = "How should decision aids be developed, and which patient outcomes should be assessed?",

author = "Diefenbach, \{Michael A.\} and Miller, \{Suzanne M.\}",

note = "Funding Information: Michael A. Diefenbach reports funding from the National Cancer Institute (5R01CA224918‐03), the Centers for Disease Control and Prevention (1 U01OH011690‐01‐00), and the American Cancer Society (RSG‐15‐021‐01CPPB) (all to Northwell Health). Suzanne M. Miller reports funding from the National Institutes of Health (CA06927, CA158019, and CA57586) and the American Cancer Society (RSG‐15‐021‐01CPPB) (all to Fox Chase Cancer Center). ",

year = "2022",

month = aug,

day = "1",

doi = "10.1002/cncr.34247",

language = "English",

volume = "128",

pages = "2988--2989",

journal = "Cancer",

issn = "0008-543X",